MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinomaMírian Romitti(Universidade Federal do Rio Grande do Sul), Ana Luiza Maia(Universidade Federal do Rio Grande do Sul)Endocrine Related CancerJanuary 30, 201610.1530/erc-15-0162Cited by 37SaveCiteExport RISWatch citationsRelated PapersReduced tissue inhibitor of metalloproteinase-2 expression is associated with advanced medullary thyroid carcinoma|Oncology Letters|2013|12